Arjun Bhadhuri

5PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersToxicology (incl. clinical toxicology)Social epidemiologySpeech pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 24, 2023
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland.

Andrea Favre-Bulle, Min Huang, Amin Haiderali

|Feb 07, 2023
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.

Andrea Favre-Bulle, Goran Bencina, Shujing Zhang

|Apr 01, 2021
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland.

Nadine Schur, Kapil Gudala, Umakanth Vudumula

|Sep 30, 2020
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.

Arjun Bhadhuri, Paul Kind, Paola Salari

|May 06, 2020
Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.

Rebecca Palmer, Munyaradzi Dimairo, Nicholas Latimer

Pageof 1

Frequent Collaborators

2 joint publications

Andrea Favre-Bulle

1 joint publications

Rebecca Palmer

1 joint publications

Munyaradzi Dimairo

1 joint publications

Nicholas Latimer